MarketFriction

Aster DM Quality Care Ltd

NSE ASTERDM · BSE 540975 · Hospital
₹708.90 +1.69%
NSE close2026-10-01
52 week range519.10 - 891.30
Market cap₹63,976 Cr.
P/E177
IPO 2018 · +273% since Nifty 500Midcap 150 Price band 20% Delivery 63.6%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales9299559741,0021,0861,0501,0001,0781,1971,1861,1821,311
Expenses7878058178418698648188769619839581,055
Operating Profit142149156161217186182202236202224256
OPM %15%16%16%16%20%18%18%19%20%17%19%20%
Other Income-64153-405,12035952928-037-77
Interest302530293131323131313031
Depreciation545758606262646366686769
Profit before tax-7220285,1911591029113616710316378
Tax %120%5%108%1%33%37%6%31%27%43%6%62%
Net Profit-15209-25,1521066486941215915429
EPS in Rs-0.623.59-0.48103.001.941.141.581.652.121.012.710.31
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales5,2505,9316,7217,9638,6528,60810,2532,9943,6994,1384,6434,876
Expenses4,8055,5826,0896,8867,1877,5068,7202,5473,1243,3833,7693,958
Operating Profit4453496321,0771,4651,1031,533447575756875918
OPM %8%6%9%14%17%13%15%15%16%18%19%19%
Other Income25453177-155-1585351353325,16891-13
Interest18937120420539133430796119133132123
Depreciation243322298306586618641192220249264270
Profit before tax381083084103302056375112685,542570511
Tax %78%10%8%10%5%13%6%7%21%2%25%
Net Profit8982823673151786014752125,408427363
EPS in Rs0.202.525.326.595.542.9610.538.512.59107.667.496.15
Dividend Payout %0%0%0%0%0%0%0%0%4,637%5%40%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth-1%-12%16%16%
Compounded Profit Growth48%23%-1%2%
Stock Price CAGR%28%31%17%
Return on Equity8%9%6%11%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital389403403505505497497500500500500518
Reserves1,096171,4722,3272,7092,7752,8753,0803,5743,6862,5543,683
Borrowings1,0913,3212,7582,3522,7885,6054,8045,2826,0751,7582,3922,594
Other Liabilities1,8342,0032,1712,2962,9263,5283,4443,6614,68712,0391,1541,280
Total Liabilities4,4095,7436,8047,4798,92812,40511,62012,52114,83617,9836,6008,076
Fixed Assets2,2372,5073,5203,7384,2897,1246,7497,0099,0523,1753,9204,242
CWIP197358290402550736934998279170293420
Investments33932382234634580172451,167
Other Assets1,9722,8392,9623,3024,0674,5113,8744,4705,42514,6202,1422,248
Total Assets4,4095,7436,8047,4798,92812,40511,62012,52114,83617,9836,6008,076
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity2362033615376011,2231,5691,3141,834158425656
Cash from Investing Activity-439-775-1,136-522-702-658-333-563-951-8786,015-288
Cash from Financing Activity20357865446134-675-1,116-686-8171,053-6,358-304
Net Cash Flow-15-1226133-11012065663328263
Free Cash Flow-176-536-56523647151,183770995-60170179
CFO/OP51%53%116%93%61%88%143%89%424%40%71%93%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days83937984931008672285232324
Inventory Days9392102111110138122129612443632
Days Payable1781871511501533032902671,400183166168
Cash Conversion Cycle-2-1304550-65-83-66-503-116-107-112
Working Capital Days696865928855-21272-32-28
ROCE %14%6%1%7%13%12%6%10%3%4%11%12%
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Jul 2026
Promoters41.88%41.88%41.88%41.88%41.88%41.89%40.39%40.39%40.39%40.39%40.39%53.72%
FIIs41.00%33.48%27.08%23.86%22.62%21.66%19.64%18.72%18.46%17.18%10.53%10.32%
DIIs7.15%13.70%16.35%20.91%22.91%24.58%25.28%26.32%26.12%27.57%27.65%16.48%
Public9.61%10.59%14.38%13.05%12.30%11.60%14.45%14.33%14.80%14.61%21.41%19.48%
Others0.37%0.35%0.32%0.30%0.28%0.26%0.25%0.23%0.23%0.23%0.00%0.00%
No. of Shareholders67,33180,9312,06,6601,74,1711,59,0381,54,0141,48,1391,47,3041,46,9981,36,8921,33,4441,33,338

Fundamentals

Market Cap₹ 63,976 Cr.
Current Price₹ 734
Stock P/E177
Book Value₹ 81.1
ROCE11.6 %
ROE11.3 %
Dividend Yield0.41 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)16%
Compounded Profit Growth (TTM)2%
Consolidated figures.
Valuation
Market capRs 36,730 Cr
Enterprise valueRs 37,998 Cr
P/E (TTM)115.26x
Price to book8.74x
Price to sales7.53x
EV / EBITDA41.98x
EV / EBIT59.86x
EV / sales7.79x
Price to cash flow56.00x
Earnings yield0.87%
Dividend yield0.42%
P/E, 3-year average84.02x
P/B, 3-year average7.02x
P/E, 5-year average59.82x
P/B, 5-year average5.35x
Profitability
Operating margin (excl. other income)18.84%
Operating margin (incl. other income)20.80%
EBITDA margin18.56%
Pre-tax margin10.49%
Net profit margin6.54%
Net margin, latest quarter1.23%
ROE10.70%
ROCE11.46%
ROA5.29%
ROE, 3-year average54.14%
ROCE, 3-year average38.64%
ROA, 3-year average16.61%
ROE, 5-year average37.73%
ROCE, 5-year average26.68%
ROA, 5-year average11.46%
ROIC (approx.)8.70%
Tax rate25.03%
Other income / net worth2.17%
Growth
Sales growth (latest year)12.20%
Profit growth (latest year)-92.78%
Sales CAGR, 3 years15.75%
Sales CAGR, 5 years-11.61%
Profit CAGR, 3 years-2.97%
Profit CAGR, 5 years21.31%
Sales growth QoQ10.85%
Profit growth QoQ-88.54%
Sales growth YoY (latest quarter)21.60%
Profit growth YoY (latest quarter)-81.22%
Per share
EPS (TTM)Rs 6.15
EPS (latest year)Rs 7.49
EPS (latest quarter)Rs 0.31
EPS, 3-year averageRs 39.25
EPS, 5-year averageRs 27.36
Book value per shareRs 81.09
Sales per shareRs 94.11
Cash flow per shareRs 12.66
Free cash flow per shareRs 3.45
Dividend per share (latest year)Rs 3.00
Dividend per share, 3-year averageRs 42.67
Dividend per share, 5-year averageRs 42.67
Dividends
Dividend payout40.05%
Dividend payout, 3-year average1560.44%
Dividend payout, 5-year average1560.44%
Efficiency
Asset turnover0.57x
Fixed asset turnover1.09x
Inventory turnover27.26x
Inventory days13 days
Debtor days24 days
Debtors turnover15.11x
Creditor days168 days
Cash conversion cycle-112 days
Working capital days-28 days
Leverage
Total debtRs 2,594 Cr
Cash and bankRs 1,325 Cr
Net debtRs 1,269 Cr
Debt to equity0.62x
Net debt / EBITDA1.40x
Interest coverage5.14x
Current ratio (filing 2026-03-31)1.99x
Quick ratio (filing 2026-03-31)1.90x
Trade payables (filing 2026-03-31)Rs 482 Cr
Owners' fund to total sources52.03%
Debt to assets32.12%
Cash flow
Cash from Operating Activity (latest year)Rs 656 Cr
Cash from Investing Activity (latest year)Rs -288 Cr
Cash from Financing Activity (latest year)Rs -304 Cr
Net Cash Flow (latest year)Rs 63 Cr
Free cash flow (latest year)Rs 179 Cr
FCFE (approx.: FCF + change in debt)Rs 381 Cr
Cash from ops / profit, 5 years0.62x
Sales to cash flow7.08x
Statement figures
Net sales (TTM)Rs 4,876 Cr
Net sales (latest year)Rs 4,643 Cr
Sales (latest quarter)Rs 1,311 Cr
Operating profit excl. other income (latest year)Rs 875 Cr
Operating profit (latest quarter)Rs 256 Cr
Other income (TTM)Rs -13 Cr
EBITDA (TTM)Rs 905 Cr
PBDT (TTM)Rs 782 Cr
Profit before tax (TTM)Rs 511 Cr
Tax (latest year)Rs 143 Cr
Net profit (TTM)Rs 319 Cr
Net profit (latest year)Rs 388 Cr
Net profit (latest quarter)Rs 16 Cr
Depreciation (TTM)Rs 270 Cr
Depreciation (latest quarter)Rs 69 Cr
Interest (TTM)Rs 123 Cr
Cost of goods sold (latest year)Rs 2,485 Cr
Total expenditure (latest year)Rs 3,769 Cr
Total income (latest year)Rs 4,734 Cr
Share capitalRs 518 Cr
ReservesRs 3,683 Cr
Shareholders' fundsRs 4,201 Cr
Total assetsRs 8,076 Cr
Net blockRs 4,242 Cr
Capital work in progressRs 420 Cr
InvestmentsRs 1,167 Cr
ReceivablesRs 307 Cr
InventoryRs 91 Cr
Other liabilitiesRs 1,280 Cr
Shares outstanding (crore)51.81
Ownership
Promoter holding53.72% (+13.33 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 115.3 is at the 90th percentile of its own 8.8-year range (median 32.5, low 4.0, high 206.0).
P/B 8.74 is at the 85th percentile (median 3.32).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodASTERDMNifty 50Difference
1 week-7.8%-2.8% -5.0 pts
1 month-6.5%-6.8% +0.3 pts
3 months-10.6%-7.6% -3.0 pts
6 months+5.8%+0.4% +5.4 pts
1 year+10.3%-9.9% +20.2 pts
2 years+67.8%-13.6% +81.4 pts
3 years+116.2%+14.2% +102.0 pts
5 years+234.6%+27.9% +206.7 pts
161 mutual fund schemes hold about ₹13,498 Cr. Over three months 104 bought more and 21 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
HDFC Small Cap Fund3.56%1,492 +4%
Kotak Mid Cap Fund1.56%1,112 +77%
HDFC Flexi Cap Fund0.81%924 +38%
HDFC Mid Cap Fund0.84%907 +142%
Kotak Small Cap Fund4.29%844 +1%
HDFC Focused Fund2.98%841 +100%
Quant Small Cap Fund2.27%807 -6%
SBI Contra Fund1.46%695 +7%
Nippon India Small Cap Fund0.80%663 +2%
Kotak Large & Mid Cap Fund1.07%345 +100%
HSBC Small Cap Fund1.50%287 +1%
HDFC Children's Fund(Lock in)2.67%284 +6%
DSP Midcap Fund1.19%251 +83%
Franklin India Opportunities Fund2.48%241 +42%
SBI Healthcare Opp Fund3.52%204 +5%
HDFC Multi Cap Fund0.86%177 +6%
HDFC Large & Mid Cap Fund0.56%170 +4%
Axis Midcap Fund0.49%168 +100%
Franklin India Small Cap Fund0.94%138 -42%
Kotak Pioneer Fund3.20%137 -2%
HDFC Pharma and Healthcare Fund3.84%127 -15%
Sundaram Small Cap Fund3.04%126 -0%
Kotak Business Cycle Fund3.56%125 +0%
Sundaram Services Fund2.33%123 +0%
SBI MNC Fund1.80%121 +35%

Red flags

F-score 5 of 8
explainWeak cash conversion Cash from operations was 21% of net profit over the last 3 years
lookRegulator order or action Regulator order or action 2026-03-25: Aster DM Healthcare Limited has informed the Exchange about Action(s) taken or orders passed
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Insider trades

NSE insider and takeover-code disclosures
DateWhoRoleSideSharesValueHow
2025-03-20Union (Mauritius) Holdings LimitedPromoter Groupother19,980,522Rs 865.16 CrPledge Creation
2025-03-20Union Investments Private LimitedPromotersother19,980,522Rs 865.16 CrRevokation of Pledge
2025-03-07Union Investments Private LimitedPromotersother85,096,820Rs 3552.37 Cr-
2025-03-04Union (Mauritius) Holdings LimitedPromoter Groupother19,980,522Rs 787.23 CrRevokation of Pledge
2025-03-04Union Investments Private LimitedPromotersother186,853,810Rs 7362.04 CrRevokation of Pledge
2024-03-12Union (Mauritius) Holdings LimitedPromoter Groupother19,980,522Rs 825.50 CrPledge Creation
2024-03-12Union Investments Private LimitedPromotersother186,853,810Rs 7719.87 CrPledge Creation
2023-03-28Union (Mauritius) Holdings LimitedPromoter Groupother19,980,522Rs 459.55 CrOff Market
2023-03-28Olympus Capital Asia Investments L-other19,980,522Rs 459.55 CrOff Market
2021-07-20Sherbaz BichuEmployees/Designated Employeother13,976Rs 0.22 CrESOP
2021-06-17Jobilal VavachanEmployees/Designated Employeother48,625Rs 0.75 CrESOP
2021-06-17Jaleel P AEmployees/Designated Employeother10,463Rs 0.16 CrESOP
Latest disclosed trades by insiders, promoters and large holders. Grants, option exercises and pledges show as "other". A filing is a fact, not a signal on its own.

Latest quarter

Jun 2026
Sales ₹1,311 Cr +21.6% vs Jun 2025. Net profit ₹29 Cr -69.1%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Apollo Hospitals Enterprise Ltd124,50359.217.4 %
Manipal Health Enterprises Ltd98,35711112.1 %
Max Healthcare Institute Ltd95,58963.814.7 %
Fortis Healthcare Ltd62,05858.213.4 %
Global Health Ltd38,04866.417.4 %
Narayana Hrudayalaya Ltd36,57942.415.5 %
Krishna Institute of Medical Sciences Ltd32,3361559.50 %
Dr Agarwals Health Care Ltd15,70110610.9 %
Rainbow Childrens Medicare Ltd13,89248.517.4 %
Park Medi World Ltd11,89842.819.5 %
Yatharth Hospital & Trauma Care Services Ltd10,67658.912.9 %
Healthcare Global Enterprises Ltd10,5052188.30 %
Jupiter Life Line Hospitals Ltd8,59144.914.8 %
Kovai Medical Center & Hospital Ltd6,57925.722.6 %
Artemis Medicare Services Ltd5,81850.414.5 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-04-02Interim Dividend - Rs 3 Per Share
2025-08-28Dividend - Re 1 Per Share
2025-02-10Interim Dividend - Rs 4 Per Share
2024-08-22Annual General Meeting/Dividend - Rs 2 Per Share
2024-04-23Special Dividend - Rs 118 Per Share
2020-01-23 Buy Back
DateTypeWhat it says
2026-09-30Shareholder meetingVoting results.
2026-09-28RetirementRetirement of Ms. Purana Housdurgam Vijayadeepti (DIN: 08125456) as Non-Executive Independent Director of the Company with effect from the conclusion ...
2026-09-28AppointmentAppointment of Mrs Neela Bhattacherjee as Non- Executive Independent Director of the company w.e.f. September 28, 2026.
2026-09-28Director changeChange in Director(s) of the company.
2026-09-28Shareholder meetingSummary proceedings of 18th Annual General Meeting held on September 28, 2026
2026-09-26Shareholder meetingVoting results.
2026-09-19General UpdatesIssue of an Addendum to the Notice of 18th Annual General Meeting of the Company.
2026-09-16Credit Rating- RevisionRevision in Credit Rating of a Material Subsidiary
2026-09-05UpdatesBusiness Responsibility and Sustainability Report for Financial Year 2025-26.
2026-09-05Shareholder meetingNotice of Annual General Meeting to be held on September 28, 2026
2026-09-04Press ReleaseA press release dated September 04, 2026, titled "Dr. Moopen family picks up additional stake in the Company".
2026-08-31Capacity additionCapacity expansion at the facility of a material subsidiary of the Company
2026-08-29Amalgamation/MergerScheme of Amalgamation of KIMSHEALTH Executive Leisure Private Limited with Spiceretreat Hospitality Services Private Limited, step-down subsidiaries ...
2026-08-28AcquisitionAcquisition of Equity Shares of STS Holdings Limited by a Subsidiary of the Company
2026-08-26Shareholder meetingNotice of Postal Ballot
2026-08-14General UpdatesReceipt of trading approval for Equity shares allotted in terms of Scheme of Amalgamation
2026-08-12Concall / analyst meetTranscript of earning conference call held for quarter ended 30 June 2026
2026-08-05Concall / analyst meetLink of Recording
2026-08-05Concall / analyst meetSchedule of meet that Company will be participating in the Non-deal Roadshow organized by Kotak Mahindra Capital Company Limited from 10 August 2026 t...
2026-08-05AcquisitionAcquisition of equity shares of United CIIGMA Institute of Medical Sciences, a subsidiary company of the Company.
2026-08-05General UpdatesThe outcome of Board Meeting held on 5 August, 2026-Others- Approval of Notice of 18th AGM and Postal Ballot and other required disclosures.
2026-08-05Press ReleaseA press release dated August 05, 2026, titled "Press release on the unaudited financial results for the quarter ended 30 June 2026".
2026-08-05Investor PresentationInvestor Presentation
2026-08-05Board meeting outcomeAster DM Quality Care Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-07-31Concall / analyst meetSchedule of Analyst/Investors call for quarter ended 30 June 2026
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Scrip PE is greater than 50 (4 trailing quarters)

Quick answers

What is the market cap of Aster DM Quality Care Ltd?

Aster DM Quality Care Ltd (ASTERDM) has a market capitalisation of Rs 63,976 Cr. at the 2026-10-01 close.

What is the P/E ratio of Aster DM Quality Care Ltd?

Aster DM Quality Care Ltd trades at a P/E of 177 on trailing twelve-month profit, at the 2026-10-01 close.

What were Aster DM Quality Care Ltd's latest quarterly results?

In the Jun 2026 quarter, Aster DM Quality Care Ltd sales was Rs 1,311 Cr (+21.6% vs Jun 2025) and net profit was Rs 29 Cr.

What is the 52-week high and low of Aster DM Quality Care Ltd?

The 52-week high is Rs 891.30 and the 52-week low is Rs 519.10.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03